Having trouble viewing this email? View it as a Web page.
What’s New at CBER
You are subscribed to What’s New at CBER for the U.S. Food & Drug Administration (FDA).
This page has been updated recently.
- August 31, 2017 Approval Letter – AFLURIA QUADRIVALENT (PDF – 34KB)